{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:39:05Z","timestamp":1792654745410,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.nucmedbio.2026.109846","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:35:10Z","timestamp":1792132510000},"page":"109846","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Production of 135La via the 136Ba(p,2n)135La reaction and its DNA-damaging properties as a low-energy Auger electron emitter"],"prefix":"10.1016","volume":"162-163","author":[{"given":"Santiago Andr\u00e9s","family":"Br\u00fchlmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristof","family":"Zarschler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Kenkadze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadiya","family":"Zhutova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Stadlbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Kopka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"Mamat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Walther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kreller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2026.109846_bb0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.critrevonc.2018.01.001","article-title":"Global comparison of targeted alpha vs targeted beta therapy for cancer: in vitro, in vivo and clinical trials","volume":"123","author":"Marcu","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"issue":"143","key":"10.1016\/j.nucmedbio.2026.109846_bb0010","article-title":"Alpha atlas: mapping global production of alpha-emitting radionuclides for targeted alpha therapy","volume":"142","author":"Tosato","year":"2025","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2026.109846_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/ph17010076","article-title":"Alpha-emitting radionuclides: current status and future perspectives","volume":"17","author":"Miederer","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.nucmedbio.2026.109846_bb0020","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.2967\/jnumed.122.265039","article-title":"Marshalling the potential of auger electron radiopharmaceutical therapy","volume":"64","author":"Bolcaen","year":"2023","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2026.109846_bb0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s41181-019-0075-2","article-title":"Auger electrons for cancer therapy - a review","volume":"4","author":"Ku","year":"2019","journal-title":"EJNMMI Radiopharm Chem"},{"key":"10.1016\/j.nucmedbio.2026.109846_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nucmedbio.2020.12.001","article-title":"Potent candidates for Targeted Auger Therapy: production and radiochemical considerations","volume":"94","author":"Filosofov","year":"2021","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2026.109846_bb0035","series-title":"The essential physics of medical imaging","author":"Bushberg","year":"2011"},{"key":"10.1016\/j.nucmedbio.2026.109846_bb0040","author":"National Nuclear Data Center"},{"key":"10.1016\/j.nucmedbio.2026.109846_bb0045","doi-asserted-by":"crossref","DOI":"10.1103\/PhysRevC.97.034312","article-title":"Half-lives of La132 and La135","volume":"97","author":"Abel","year":"2018","journal-title":"Phys Rev C"},{"key":"10.1016\/j.nucmedbio.2026.109846_bb0050","doi-asserted-by":"crossref","first-page":"015026","DOI":"10.1088\/1361-6560\/aa9b44","article-title":"135La as an auger-electron emitter for targeted internal radiotherapy","volume":"63","author":"Fonslet","year":"2017","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.nucmedbio.2026.109846_bb0055","article-title":"ICRP publication 107: nuclear decay data for dosimetric calculations","volume":"38","author":"International Commission on Radiological Protection","year":"2008","journal-title":"Ann ICRP"},{"key":"10.1016\/j.nucmedbio.2026.109846_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161973","article-title":"Direct and auger electron-induced, single- and double-strand breaks on plasmid DNA caused by 99mTc-labeled pyrene derivatives and the effect of bonding distance","volume":"11","author":"Reissig","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.nucmedbio.2026.109846_bb0065","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.nucmedbio.2016.10.008","article-title":"Re-assessing gallium-67 as a therapeutic radionuclide","volume":"46","author":"Othman","year":"2017","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2026.109846_bb0070","doi-asserted-by":"crossref","first-page":"530","DOI":"10.2307\/3580150","article-title":"Strand breaks in plasmid DNA after positional changes of auger electron-emitting iodine-125: direct compared to indirect effects","volume":"152","author":"Kassis","year":"1999","journal-title":"Radiat Res"},{"key":"10.1016\/j.nucmedbio.2026.109846_bb0075","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.nimb.2021.07.002","article-title":"Stopping power and CSDA range of electrons in liquid water, LiF, CaF2, and Al2O3 from the energy gap up to 433 keV","volume":"502","author":"Castillo-Rico","year":"2021","journal-title":"Nucl Instrum Methods Phys Res, Sect B"},{"key":"10.1016\/j.nucmedbio.2026.109846_bb0080","author":"National Institute of Standards and Technology (NIST)"},{"key":"10.1016\/j.nucmedbio.2026.109846_bb0085","doi-asserted-by":"crossref","first-page":"10658","DOI":"10.1038\/s41598-019-47137-0","article-title":"Production and in vivo PET\/CT imaging of the theranostic pair 132\/135La","volume":"9","author":"Aluicio-Sarduy","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.nucmedbio.2026.109846_bb0090","doi-asserted-by":"crossref","first-page":"394","DOI":"10.2174\/1874471014999210111201630","article-title":"Meitner-auger electron emitters for targeted radionuclide therapy: mercury-197m\/g and antimony-119","volume":"14","author":"Randhawa","year":"2021","journal-title":"Curr Radiopharm"},{"key":"10.1016\/j.nucmedbio.2026.109846_bb0095","doi-asserted-by":"crossref","first-page":"18837","DOI":"10.1038\/s41598-023-43429-8","article-title":"Preclinical evaluation of [58mCo] co-DOTA-PSMA-617 for auger electron therapy of prostate cancer","volume":"13","author":"Baun","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.nucmedbio.2026.109846_bb0100","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1118\/1.3608905","article-title":"Production and dosimetric aspects of the potent auger emitter 58mCo for targeted radionuclide therapy of small tumors","volume":"38","author":"Thisgaard","year":"2011","journal-title":"Med Phys"},{"key":"10.1016\/j.nucmedbio.2026.109846_bb0105","doi-asserted-by":"crossref","DOI":"10.1186\/s40658-018-0216-9","article-title":"Molecular imaging using the theranostic agent 197(m)Hg: phantom measurements and Monte Carlo simulations","volume":"5","author":"Freudenberg","year":"2018","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.nucmedbio.2026.109846_bb0110","doi-asserted-by":"crossref","DOI":"10.1186\/s13550-026-01493-x","article-title":"A preclinical investigation of 135La-labelled SSTR2 agonist and antagonist for auger electron therapy","author":"Spoormans","year":"2026","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.nucmedbio.2026.109846_bb0115","doi-asserted-by":"crossref","first-page":"22203","DOI":"10.1038\/s41598-020-79198-x","article-title":"High yield cyclotron production of a novel 133\/135La theranostic pair for nuclear medicine","volume":"10","author":"Nelson","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.nucmedbio.2026.109846_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.apradiso.2022.110612","article-title":"Improved procedures for production and purification of 135La from enriched [135Ba]BaCO3 on a 16.5 MeV cyclotron","volume":"192","author":"Pedersen","year":"2023","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2026.109846_bb0125","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1515\/ract-2015-2427","article-title":"Production of no-carrier-added 135La at an 18\u202fMeV cyclotron and its purification for investigations at a concentration range down to 10\u221215\u202fmol\/l","volume":"103","author":"Mansel","year":"2015","journal-title":"Radiochimica Acta"},{"key":"10.1016\/j.nucmedbio.2026.109846_bb0130","article-title":"Production and purification of radiolabeling-ready 132\/135La from the irradiation of metallic natBa targets with low energy protons","volume":"144","author":"Kurakina","year":"2025","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2026.109846_bb0135","doi-asserted-by":"crossref","DOI":"10.1140\/epjp\/s13360-024-05917-2","article-title":"Proton-induced nuclear reactions on barium-136 for the production of the medically relevant radionuclide lanthanum-135","volume":"139","author":"Khomenko","year":"2024","journal-title":"Eur Phys J Plus"},{"key":"10.1016\/j.nucmedbio.2026.109846_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13081974","article-title":"Towards targeted alpha therapy with actinium-225: chelators for mild condition radiolabeling and targeting PSMA-a proof of concept study","volume":"13","author":"Reissig","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.nucmedbio.2026.109846_bb0150","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s41181-024-00292-w","article-title":"Scalability study on [133La]LaCl3 production with a focus on potential clinical applications","volume":"9","author":"Br\u00fchlmann","year":"2024","journal-title":"EJNMMI Radiopharm Chem"},{"key":"10.1016\/j.nucmedbio.2026.109846_bb0155","series-title":"The international conference on cyclotrons and their applications","first-page":"166","article-title":"The cyclotron TR-FLEX at the center for radiopharmaceutical cancer research at Helmholtz-Zentrum Dresden-Rossendorf","author":"Kreller","year":"2019"},{"key":"10.1016\/j.nucmedbio.2026.109846_bb0160","series-title":"Treatise on heavy-ion science","first-page":"93","article-title":"The stopping and range of ions in matter","author":"Ziegler","year":"1985"},{"key":"10.1016\/j.nucmedbio.2026.109846_bb0165","author":"Mirion Technologies (Canberra)"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805126002453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805126002453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:56:57Z","timestamp":1792652217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805126002453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":32,"alternative-id":["S0969805126002453"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2026.109846","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Production of 135La via the 136Ba(p,2n)135La reaction and its DNA-damaging properties as a low-energy Auger electron emitter","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2026.109846","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109846"}}